EdisonTV

BB Healthcare Trust

EdisonTV | Financials | 21/06/2017

Executive Interview - BB Healthcare Trust

Paul Major, fund manager of BB Healthcare Trust (launched December 2016), gives an overview of the investment trust and how it sits alongside manager Bellevue Asset Management’s long-established BB Biotech fund. He explains how the high-conviction strategy differs from peers, not just in its concentrated portfolio drawn from across the healthcare universe, but also in its 3.5% distributions and annual redemption facility. Major goes on to explore why investors should consider looking at the healthcare sector, which is supported by scientific innovation and demographic change, and looks ahead to the rest of the year, a period in which he expects fundamentals for the sector to reassert themselves following a period where political debate has dominated the headlines.
BB Healthcare Trust (BBH) is an investment trust concentrating on the global healthcare sector. It holds a focused and actively managed portfolio of a maximum of 35 investments chosen for their capital growth potential. Structured as a UK-listed investment trust, the fund targets an annual dividend of 3.5% of NAV, which it manufactures largely from capital returns rather than being constrained by investing in high-yielding stocks. It offers an annual redemption facility as a means of minimising any potential discount to NAV.

Executive Interview - BB Healthcare Trust

Executive Interview - BB Healthcare Trust

Paul Major, fund manager of BB Healthcare Trust (launched December 2016), gives an overview of the investment trust and how it sits alongside manager Bellevue Asset Management’s long-established BB Biotech fund. He explains how the high-conviction strategy differs from peers, not just in its concentrated portfolio drawn from across the healthcare universe, but also in its 3.5% distributions and annual redemption facility. Major goes on to explore why investors should consider looking at the healthcare sector, which is supported by scientific innovation and demographic change, and looks ahead to the rest of the year, a period in which he expects fundamentals for the sector to reassert themselves following a period where political debate has dominated the headlines.
Watch »

21/06/2017 | BB Healthcare Trust

Executive Interview - Gervais Williams

Executive Interview - Gervais Williams

Gervais discusses his third book, The Retreat of Globalisation. In the book he explains how he views the current period as one of profound change in social attitudes.
Watch »

13/12/2016 |

Executive Interview - Tungsten Corporation

Executive Interview - Tungsten Corporation

Tungsten Corporation offers a secure e-invoicing platform including Tungsten Analytics and Tungsten Early Payment, a form of alternative finance for businesses. Tungsten serves 56% of the Fortune 500 and 67% of the FTSE 100. It enables suppliers to submit tax-compliant e-invoices in 47 countries, and last year processed transactions worth more than $187bn for global companies including Alliance Data, Lufthansa, General Motors, GlaxoSmithKline, Henkel, IBM, Kellogg’s and the US Federal Government.
Watch »

22/02/2016 | Tungsten Corporation

Executive Interview - Covercy

Executive Interview - Covercy

Covercy is a private company that provides an online international bank-to-bank transfer service, with a focus on commercial transactions, typically ranging from $1,000 to $50,000 per transaction, paid to or by small and medium-sized enterprises. It harnesses peer-to-peer technology to allow cross-border transfers via an efficient, easy-to-use, secure and low-cost method. For example, clients in the UK already save an average 73% on their SWIFT and exchange bank fees by using Covercy’s services. Covercy is regulated as an Authorised Payment Institution by the UK FCA, (which allows it to operate across the EU), as well as a currency services provider by the Israeli Ministry of Finance. Founded in 2015, headquartered in the unique technology hub of Tel-Aviv, Israel, and with a London office, Covercy currently has double digit month-on-month transaction volume growth.
Watch »

06/11/2015 | Covercy

Executive Interview - NZX Limited

Executive Interview - NZX Limited

NZX operates the New Zealand capital markets, agricultural commodities and NZ energy markets. It provides the trading mechanisms and infrastructure, develops products and provides the data and information that drive trading activity. In January 2015 NZX acquired 100% of Superlife, a provider of superannuation products with NZ$1.2bn under management, for a total payment of up to NZ$35m. This acquisition will help NZX grow its passive funds management business and help it develop its portfolio of exchange-traded funds (ETFs).
Watch »

21/10/2015 |

Executive Interview - Heartland New Zealand

Executive Interview - Heartland New Zealand

Heartland New Zealand (HNZ) is a community-based financial institution focused on households, consumer and rural sectors in New Zealand. It has a diversified asset base, a balanced geographic footprint and a widespread depositor base. In FY15 deposit growth was ~20% and strong growth is expected in FY16. The cost-to-income ratio continues to improve as HNZ adds scale via organic growth and acquisitions. Growth is primarily driven by GDP and employment in New Zealand.
Watch »

21/10/2015 |

Executive Interview - Burford Capital

Executive Interview - Burford Capital

Burford Capital is the world’s largest provider of litigation finance. Listed on the London Stock Exchange, it is almost unique in its asset class. The sector and the company have seen strong growth in recent years. In this interview CEO Christopher Bogart explains Burford’s business model and investment case.
Watch »

05/05/2015 |

Executive Interview - Avation plc

Executive Interview - Avation plc

Avation is an aircraft leasing company whose main business is delivering short-haul aircraft to regional airlines in the Asia Pacific region, although the company has an increasing presence in Europe and South America. CFO Richard Wolanski has helped Avation grow rapidly over the last few years, and gives an overview of the business, a specific look at recent deals and tells us what to expect from the company in the coming year.
Watch »

05/05/2015 |

Executive Interview - Imperial Innovations

Executive Interview - Imperial Innovations

Imperial Innovations (IVO) is a technology transfer, incubation and venture investment company. It invests in ventures from Imperial College London, Cambridge and Oxford universities and UCL (the "Golden Triangle"). More than 90% of its portfolio value is in 20 companies, with the majority (c 70%) of its investment value in Healthcare and the remainder in Materials/Engineering (c 20%) and ICT/Digital (c 10%). In this webcast, CEO Russ Cummings provides an overview of key recent developments at Innovations, discusses trends in the increasingly buoyant field of life science investment companies and looks ahead to upcoming milestones for the group. Russ talks about the balance of the portfolio, which has benefited from strong growth in its therapeutics companies (eg Circassia’s IPO on the London main market) and contrasts the investment case for Innovations with other UK-listed investment companies. One key development last year was a £150m capital raise, so Russ discusses how the group intends to deploy this capital across its portfolio of companies and highlights some important recent investments, such as leading a £50m round in Cell Medica and an £18m round in Veryan Medical.
Watch »

16/03/2015 |

Heartland New Zealand Ltd

Heartland New Zealand Ltd

Heartland New Zealand was created by merger in January 2011 and focuses on providing financial services to its core markets of SMEs, rural (ie farms, farm machinery and livestock) and households. It focuses on the less contested sectors to achieve a better risk/return balance.
Watch »

17/02/2015 | Heartland New Zealand

Executive Interview - Park Group

Executive Interview - Park Group

Park Group is a financial services business. It is one of the UK’s leading multi-retailer gift voucher and prepaid gift card businesses, focused on the corporate gift and consumer markets. Sales are generated via e-commerce, a direct sales force and agents. In this short video, Chris Houghton, CEO of Park Group, discusses the transformation of the group in recent years, focused on vouchers and pre-paid cards, supported by long-term investment in digital technology. Recent growth has been driven by the flexecash pre-paid card that was developed in house and introduced in 2010. The recent interim results, which saw the seasonal H1 loss reduce on strong top-line growth, are also discussed, as well as the outlook for the full year.
Watch »

18/12/2014 | Park Group

Executive Interview – S&U

Executive Interview – S&U

S&U is a niche consumer and motor finance provider to the non-standard UK market. It distributes the former through agents to customers’ homes and the latter through brokers. It has over 140,000 customers and more than 800 employees and home credit agents. The family business is firing on all cylinders. S&U has produced results above forecasts (pre-tax profit £17.3m against our £16.6m), driven by revenue £0.8m better than anticipated. The strong growth in motor credit has continued (profit up 42%), with an increasing number of customers falling into its target niche and market share gains by delivering good service to brokers. Home Collect saw growing volumes in its fourth quarter to end January 2014 (advances up 8% on the same period last year). Chairman Anthony Coombs reviews the regulatory environment, the excellent growth seen in the motor business and the return to growth in the home collect business.
Watch »

07/04/2014 | S&U

Executive Interview – Imperial Innovations

Executive Interview – Imperial Innovations

Imperial Innovations is a technology transfer, incubation and venture investment company. Russ Cummings, CEO, discusses how Imperial Innovations focuses on building companies and its experience in establishing high-quality management teams and attracting quality co-investors to these companies, often validating the technology. He suggests Oxford Immunotec’s recent successful NASDAQ IPO demonstrates Imperial Innovations’ ambition and provides an example of the quality in its portfolio. Moreover, given the current favourable stockmarket conditions, many other companies in Imperial Innovations’ portfolio are now examining their own funding options.
Watch »

27/01/2014 |

Executive Interview - City of London Group

Executive Interview - City of London Group

Eric Anstee, Chief Executive of City of London Group, who discusses the company’s preliminary results. City of London Group is the majority owner of specialist lending platforms, exploiting niche markets where banks have limited appetite to lend. The key platforms provide SME trade finance, SME leasing, lending to professions and litigation funding. Each independent unit requires specific skills and we expect them all to show significant growth from small bases.
Watch »

26/06/2013 | City of London Group

IFG Group

IFG Group

UK SIPPs are the most important element of IFG’s profits stream, providing opportunities for strong organic long-term growth and is the area most likely for further acquisition. The expected post-tax ROI on the James Hay deal is c 20% and its effective integration and delivery of synergies are important in establishing credibility for further acquisitions.
Watch »

20/12/2012 | IFG Group